Drug Makers Said to Lag in New Markets

the leading drug makers are underperforming in emerging markets. The top 15 pharmaceutical companies, including Pfizer, Merck and Eli Lilly, together derive less than 10 percent of their sales from emerging markets, IMS said. To build profitable...